Share this article
Company to begin limited market release in Europe in June
MARLBOROUGH, Mass., May 25, 2021 /PRNewswire/ Boston Scientific Corporation (NYSE: BSX) today announced it has completed CE Mark for the EXALT™ Model B Single-Use Bronchoscope, a single-use device designed for bedside procedures in the intensive care unit, operating room and bronchoscopy suite. Limited market release of the device is expected to commence in Europe in the coming weeks.
EXALT Model B Bronchoscope (PRNewsfoto/Boston Scientific Corporation)
EXALT Model B Bronchoscope and Monitor (PRNewsfoto/Boston Scientific Corporation)
The EXALT Model B Bronchoscope will be offered in three sizes – slim, regular and large – to allow for use in a wide variety of bronchoscopy procedures such as secretion management, airway intubation, percutaneous tracheostomy, double lumen endotracheal tube placement and biopsies.
Boston Scientific Completes CE Mark for EXALT Model B Single-Use Bronchoscope
Company to begin limited market release in Europe in June
MARLBOROUGH, Mass., May 25, 2021 /PRNewswire/ Boston Scientific Corporation (NYSE: BSX) today announced it has completed CE Mark for the EXALT Model B Single-Use Bronchoscope, a single-use device designed for bedside procedures in the intensive care unit, operating room and bronchoscopy suite. Limited market release of the device is expected to commence in Europe in the coming weeks.
The EXALT Model B Bronchoscope will be offered in three sizes - slim, regular and large - to allow for use in a wide variety of bronchoscopy procedures such as secretion management, airway intubation, percutaneous tracheostomy, double lumen endotracheal tube placement and biopsies.
Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to Build A World-leading Platform for Innovative Products in Endoscope and Related Fields
BriefingWire.com, 4/25/2021 - Scivita Medical Technology Co., Ltd. (Scivita Medical) today announced that it has raised nearly RMB0.4 Billion in Series A funding round, which has become one of the highest financing projects in the field of endoscope in China in recent years. The investment was jointly led by GL Ventures and Lilly Asia Ventures, with contribution from Matrix Partners China, Medtronic, Chengwei Capital and Shanghai Innochip Investment. The successful completion of the Series A funding round reflects the recognition of Scivita Medical in the field of endoscope and the expectation of its future development from the capital market and industrial strategic partners. Sci
CorNeat Vision Partners with LiveU and Alcon for Remote Surgeon Virtual Presence
USA - English
News provided by
Share this article
Share this article
RA ANANA, Israel, March 8, 2021 /PRNewswire/ CorNeat Vision, a clinical-stage, biomimetic implant and technology company, and LiveU, a company offering high quality live video streaming and remote production solutions, announced today that they have partnered and successfully implemented an on-demand
Remote Surgeon Virtual Presence (RSVP) solution. The companies cooperated with Alcon to leverage its NGENUITY® 3D Visualization System to successfully perform remote supervised hands-on training of Canadian cornea experts located at the Kensington Eye Institute in Toronto, without leaving Israel. The solution, which was engineered to address COVID-19 travel restrictions, enabled initiation of the Canadian clinical site toward first implantations of the CorNeat KPro artificial cornea.